Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 6.59%.

  • Nephros' EBIT Margin rose 7400.0% to 6.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.06%, marking a year-over-year increase of 151500.0%. This contributed to the annual value of 0.04% for FY2024, which is 112300.0% up from last year.
  • Nephros' EBIT Margin amounted to 6.59% in Q3 2025, which was up 7400.0% from 5.61% recorded in Q2 2025.
  • In the past 5 years, Nephros' EBIT Margin registered a high of 11.61% during Q1 2025, and its lowest value of 71.65% during Q1 2022.
  • Its 5-year average for EBIT Margin is 18.32%, with a median of 12.27% in 2023.
  • Its EBIT Margin has fluctuated over the past 5 years, first crashed by -344500bps in 2022, then surged by 633800bps in 2023.
  • Quarter analysis of 5 years shows Nephros' EBIT Margin stood at 26.58% in 2021, then dropped by -2bps to 27.09% in 2022, then increased by 26bps to 19.94% in 2023, then surged by 141bps to 8.19% in 2024, then decreased by -20bps to 6.59% in 2025.
  • Its EBIT Margin stands at 6.59% for Q3 2025, versus 5.61% for Q2 2025 and 11.61% for Q1 2025.